Accolade Pharmaceuticals, LLC is a development-stage specialty biopharmaceutical company focused on developing a range of products for the treatment of atopic and inflammatory allergic conditions. Our team is dedicated to re-purposing Zafirlukast, a known Leukotriene Receptor Antagonist (LTRA) and approved drug product sold as Accolate®.
LTRAs are a unique class of small molecules approved for the treatment of asthma. Accolade recognizes the potential of the non-steroidal, anti-inflammatory effects of Zafirlukast for the treatment of other inflammatory conditions.
Accolade is pioneering the re-purposing and use of Zafirlukast for atopic and allergic conditions with several proprietary formulations to treat the eyes, skin, nose and airway.
Developing better treatments for atopic and allergic conditions of the eyes, skin, nose, and airway
Treating Allergic Inflammation